Title: Oligomerization of a membrane protein correlates with its retention in the Golgi complex  Document date: 1993_9_2
                    ID: 5z1xminb_4
                    
                    Snippet: Dr. Ann M. Swifts current address is Smithkline Beecham Pharmaceuticals, Philadelphia, PA. 1992). When cDNA encoding the M protein is expressed in animal cells, the protein is targeted to the cis-Golgi (Machamer et al., 1990) . Structurally, the IBV M protein consists of a short glycosylated amino-terminal domain, three membrane-spanning domains, and a long carboxyterminal cytoplasmic domain. The first membrane-spanning domain (ml) of the M glyco.....
                    
                    
                    
                     
                    
                    
                    
                    
                        
                            
                                Document: Dr. Ann M. Swifts current address is Smithkline Beecham Pharmaceuticals, Philadelphia, PA. 1992). When cDNA encoding the M protein is expressed in animal cells, the protein is targeted to the cis-Golgi (Machamer et al., 1990) . Structurally, the IBV M protein consists of a short glycosylated amino-terminal domain, three membrane-spanning domains, and a long carboxyterminal cytoplasmic domain. The first membrane-spanning domain (ml) of the M glycoprotein is sufficient to retain this protein in the Golgi (Machamer and Rose, 1987) . Furthermore, the ml domain can confer Golgi localization to a wellcharacterized plasma membrane protein (the G protein of vesicular stomatitis virus, or VSV G). VSV G is a type I membrane protein which is cotranslationally inserted into the ER, where it forms homotrimers. It is then rapidly transported through the Golgi complex (as determined by the kinetics of N-linked oligosaccharide processing) and delivered to the plasma membrane (for review see Doms et al., 1993) . When the membrane-spanning domain of VSV G is replaced with the ml domain of IBV M, the resulting chimera (Gml, see Fig. 1 ) is retained in the Golgi complex (Swift and Machamer, 1991) . Extensive mutagenesis suggests that at least four specific amino acids in the ml domain are critical for Golgi retention of Gml: asparagine 465, threonines 469 and 476, and glutamine 480 (Machamer et al., 1993) . Interestingly, these residues form an uncharged polar face along one side of the alpha helix predicted for ml. The polar nature of this face of the helix suggests that protein-protein interactions along this face may mediate Golgi retention of Gml.
 
  Search related documents: 
                                Co phrase  search for related documents- alpha helix and amino terminal: 1, 2, 3, 4
  - alpha helix and amino terminal domain: 1
  - alpha helix and cytoplasmic domain: 1
  - alpha helix and Golgi complex: 1, 2, 3
  - alpha helix and Golgi complex transport: 1
  - alpha helix and Golgi retention: 1, 2, 3, 4
  - alpha helix and helix face: 1, 2, 3, 4, 5, 6
  - alpha helix and membrane protein: 1, 2, 3, 4, 5
  - alpha helix and ml domain: 1, 2
  - alpha helix and ml domain amino acid: 1
  - alpha helix and oligosaccharide processing: 1
  - alpha helix and plasma membrane: 1, 2, 3, 4, 5
  - alpha helix and plasma membrane protein: 1, 2, 3
  - alpha helix and polar face: 1, 2, 3, 4, 5
  - alpha helix and polar nature: 1
  - alpha helix and protein protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
  - alpha helix and protein protein interaction: 1
  - alpha helix and stomatitis virus: 1, 2
  - alpha helix and uncharged polar face: 1, 2, 3
  
 
                                Co phrase  search for related documents, hyperlinks ordered by date